Cancer Screening 2011: Good, but Not Good Enough - EmpowHER.com


If you get all the recommended cancer screenings, how safe are you? Dr. Billy U. Philips Jr. and colleagues at Texas Tech University performed a unique study to find out. The purpose of cancer screening tests is to find the malignancy early, while it can be treated successfully. A major distinction between early and late stage cancer is the presence of metastases. Philips used data from the Texas Cancer Registry to check the ratio of metastatic to non-metastatic cancer diagnoses in Texas on a county by county basis. His team of researchers also analyzed data from the U.S. Census Bureau to quantify the degree of socioeconomic wealth or deprivation for each county. Statistical correlation then provided a measure of the success of improved health care for cancer.

Read the full story >>

Related Stories

Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership

From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.

Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas

The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.

TTUHSC Names New Regional Dean for the School of Nursing

Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.

Recent Stories

Research

TTUHSC’s Hudson Set to Serve as President for Society of Clinical Research Associates

The Society of Clinical Research Associates (SOCRA) has elected Texas Tech University Health Sciences Center’s (TTUHSC) Catherine Hudson, Dr.P.H., as its president for 2025-2026.

Research

Clinical Research Institute a Source of Pride for Retiring Griswold

Upon his retirement, John Griswold, M.D., reflects on the Clinical Research Institute and what it has achieved.

Research

Abid Brings Hematology Expertise to TTUHSC Oncology Team

Muhammad Bilal Abid, M.D., has joined the TTUHSC School of Medicine oncology team as an associate professor of internal medicine and medical director of TTUHSC’s Blood and Marrow Transplantation & Cellular Therapy Program.